TELA Bio (TELA) Change in Receivables (2018 - 2026)
TELA Bio (TELA) posted quarterly Change in Receivables of -$593000.0 for Q1 2026, down 247.51% year-over-year from $402000.0 in Q1 2025, and up 36.37% quarter-over-quarter from -$932000.0 in Q4 2025.
TELA Bio (TELA) Change in Receivables (2018 - 2026) Analysis & Trends
TELA Bio's Change in Receivables history runs 9 years deep, the most recent figure standing at -$593000.0 for Q1 2026.
- In Q1 2026, Change in Receivables fell 247.51% year-over-year to -$593000.0; the TTM figure through Mar 2026 stood at -$885000.0 (down 195.16% YoY), while the FY2025 annual figure was $110000.0, down 85.56% from the prior year.
- Change in Receivables for Q1 2026 stood at -$593000.0, up from -$932000.0 in the prior quarter.
- The five-year high for Change in Receivables was $2.0 million in Q3 2024, with the low at -$983000.0 in Q4 2024.
- The 5-year median for Change in Receivables is $237000.0 (2023), against an average of $338705.9.
- The sharpest annual moves came in 2024 and 2026: Change in Receivables surged 1200.0% in 2024, then plunged 247.51% in 2026.
- TELA Bio's Change in Receivables stood at $890000.0 in 2022, then soared by 80.0% to $1.6 million in 2023, then sank by 161.36% to -$983000.0 in 2024, then advanced by 5.19% to -$932000.0 in 2025, then surged by 36.37% to -$593000.0 in 2026.
- Business Quant data shows TELA's Change in Receivables at -$593000.0 in Q1 2026, -$932000.0 in Q4 2025, and $107000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | - |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -90.00 Mn |
| 10 | TELA Bio | 35.91 Mn | 5.49 Mn | 13.94 Mn | -89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -89,000.00 |
| Jun 30, 2026 | -89,000.00 |
| Mar 31, 2026 | -593,000.00 |
| Mar 31, 2026 | -593,000.00 |
| Dec 31, 2025 | -932,000.00 |
| Dec 31, 2025 | -932,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Jun 30, 2025 | 533,000.00 |
| Jun 30, 2025 | 533,000.00 |
| Mar 31, 2025 | 402,000.00 |
| Mar 31, 2025 | 402,000.00 |
| Dec 31, 2024 | -983,000.00 |
| Dec 31, 2024 | -983,000.00 |
| Sep 30, 2024 | 2.01 Mn |
| Sep 30, 2024 | 2.01 Mn |
| Jun 30, 2024 | -497,000.00 |
| Jun 30, 2024 | -497,000.00 |
| Mar 31, 2024 | 234,000.00 |
| Mar 31, 2024 | 234,000.00 |